Evidence map›Paper›PMID 36776877›Full record

ReviewFrontiers in immunology2023

T cells and their products in diabetic kidney disease.

Yue Liu, Yaodong Lv, Tingwei Zhang, Tongtong Huang, Yating Lang, Qinghao Sheng, Yingxiao Liu, Zhijuan Kong, Ying Gao, Shangwei Lu and 4 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Inflammation and Diabetic Kidney Disease.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Aging-related CD8PeerJ · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Yue LiuDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Yaodong LvDepartment of Neurology, Yantai Yuhuangding Hospital, Shandong University, Yantai, China.
Tingwei ZhangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Tongtong HuangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Yating LangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Qinghao ShengDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Yingxiao LiuDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zhijuan KongDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Ying GaoDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Shangwei LuDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Meilin YangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Yaqi LuanDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xining WangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zhimei LvDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Shandong Provincial Hospital · CNShandong First Medical University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease and has gradually become a public health problem worldwide. DKD is increasingly recognized as a comprehensive inflammatory disease that is largely regulated by T cells. Given the pivotal role of T cells and T cells-producing cytokines in DKD, we summarized recent advances concerning T cells in the progression of type 2 diabetic nephropathy and provided a novel perspective of immune-related factors in diabetes. Specific emphasis is placed on the classification of T cells, process of T cell recruitment, function of T cells in the development of diabetic kidney damage, and potential treatments and therapeutic strategies involving T cells.

Indexed as

Diabetes MellitusDiabetic NephropathiesKidney Failure, ChronicCytokinesHumansT-LymphocytesCytokinescytokinesdiabetic kidney diseasedifferentiationimmunologic functionrecruitmentT cellstherapeutic methods

Identifiers

PMID36776877
PMCPMC9909022
OpenAlexW4318049593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.